Trial intelligence / Profile preview

Resveratrol in IVF/ICSI for Unexplained Infertility

NCT06481696Recruiting

Sponsor
Andros Day Surgery Clinic
Start
Jun 2024
Primary completion
Dec 2025
Countries
1
01

Overview

Randomised, double-blind trial (2 arms), sponsored by Andros Day Surgery Clinic. Primary endpoints: Follicle Output Rate, Follicle to Oocyte Index and 2 more. Started Jun 2024; status: recruiting.

Beyond the preview

Go deeper on NCT06481696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06481696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call